BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 17153405)

  • 1. Evaluation of TG-43 recommended 2D-anisotropy function for elongated brachytherapy sources.
    Awan SB; Meigooni AS; Mokhberiosgouei R; Hussain M
    Med Phys; 2006 Nov; 33(11):4271-9. PubMed ID: 17153405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric characteristics of the new RadioCoil 103Pd wire line source for use in permanent brachytherapy implants.
    Meigooni AS; Zhang H; Clark JR; Rachabatthula V; Koona RA
    Med Phys; 2004 Nov; 31(11):3095-105. PubMed ID: 15587663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TG-43U1 parameterization of elongated RadioCoil 103Pd brachytherapy sources.
    Dini SA; Awan SB; Dou K; Meigooni AS
    J Appl Clin Med Phys; 2007 Jul; 8(3):60-75. PubMed ID: 17712301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of miniature electronic brachytherapy x-ray sources based on TG-43U1 formalism using Monte Carlo simulation techniques.
    Safigholi H; Faghihi R; Jashni SK; Meigooni AS
    Med Phys; 2012 Apr; 39(4):1971-9. PubMed ID: 22482618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monte Carlo calculation of dosimetry parameters for the IR08-103Pd brachytherapy source.
    Saidi P; Sadeghi M; Shirazi A; Tenreiro C
    Med Phys; 2010 Jun; 37(6):2509-15. PubMed ID: 20632562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source.
    Sheikholeslami S; Nedaie HA; Sadeghi M; Pourbeigy H; Shahzadi S; Zehtabian M; Hasani M; Meigooni AS
    J Appl Clin Med Phys; 2016 Jul; 17(4):430-441. PubMed ID: 27455485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cylindrical coordinate based TG-43U1 parameters for dose calculation around elongated brachytherapy sources.
    Awan SB; Dini SA; Hussain M; Soleimani-Meigooni D; Meigooni AS
    J Appl Clin Med Phys; 2008 Apr; 9(2):123-142. PubMed ID: 18714281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
    Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
    Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theoretical and experimental determination of dosimetric characteristics for ADVANTAGE Pd-103 brachytherapy source.
    Meigooni AS; Dini SA; Awan SB; Dou K; Koona RA
    Appl Radiat Isot; 2006 Aug; 64(8):881-7. PubMed ID: 16713277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of cylindrical coordinates for treatment planning parameters of an elongated 192Ir source.
    Patel NS; Chiu-Tsao ST; Fan P; Tsao HS; Liprie SF; Harrison LB
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1093-102. PubMed ID: 11704334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy assessment of the superposition principle for evaluating dose distributions of elongated and curved 103Pd and 192Ir brachytherapy sources.
    Bannon EA; Yang Y; Rivard MJ
    Med Phys; 2011 Jun; 38(6):2957-63. PubMed ID: 21815369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new treatment planning formalism for catheter-based beta sources used in intravascular brachytherapy.
    Patel NS; Chiu-Tsao ST; Tsao HS; Harrison LB
    Cardiovasc Radiat Med; 2001; 2(3):157-64. PubMed ID: 11786322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brachytherapy dosimetry parameters calculated for a new 103Pd source.
    Rivard MJ; Melhus CS; Kirk BL
    Med Phys; 2004 Sep; 31(9):2466-70. PubMed ID: 15487726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monte carlo investigation of the dosimetric properties of the new 103Pd BrachySeedPd-103 Model Pd-1 source.
    Chan GH; Prestwich WV
    Med Phys; 2002 Sep; 29(9):1984-90. PubMed ID: 12349919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional fitting of interstitial brachytherapy dosimetry data recommended by the AAPM Radiation Therapy Committee Task Group 43. American Association of Physicists in Medicine.
    Furhang EE; Anderson LL
    Med Phys; 1999 Feb; 26(2):153-60. PubMed ID: 10076967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment planning consideration for prostate implants with the new linear RadioCoil 103Pd brachytherapy source.
    Meigooni AS; Awan SB; Rachabatthula V; Koona RA
    J Appl Clin Med Phys; 2005; 6(3):23-36. PubMed ID: 16143789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A revised dosimetric characterization of the model S700 electronic brachytherapy source containing an anode-centering plastic insert and other components not included in the 2006 model.
    Hiatt JR; Davis SD; Rivard MJ
    Med Phys; 2015 Jun; 42(6):2764-76. PubMed ID: 26127029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monte Carlo-aided dosimetry of a new high dose-rate brachytherapy source.
    Daskalov GM; Löffler E; Williamson JF
    Med Phys; 1998 Nov; 25(11):2200-8. PubMed ID: 9829246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monte Carlo dosimetric characterization of the IsoAid ADVANTAGE 103Pd brachytherapy source.
    Sowards KT
    J Appl Clin Med Phys; 2007 Mar; 8(2):18-25. PubMed ID: 17592461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations of the American Association of Physicists in Medicine regarding the impact of implementing the 2004 task group 43 report on dose specification for 103Pd and 125I interstitial brachytherapy.
    Williamson JF; Butler W; Dewerd LA; Huq MS; Ibbott GS; Mitch MG; Nath R; Rivard MJ; Todor D;
    Med Phys; 2005 May; 32(5):1424-39. PubMed ID: 15984693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.